CSPC Pharmaceutical Group Limited (HKG: 1093)

CSPC Pharmaceutical Group Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	-	12,015	10,298	9,284	7,296	4,118
Short-Term Investments	-	1,750	4,268	2,024	2,019	1,643
Trading Asset Securities	-	-	-	-	-	0.54
Cash & Short-Term Investments	10,817	13,765	14,566	11,307	9,316	5,762
Cash Growth	-	-5.50%	28.82%	21.38%	61.67%	9.78%
Accounts Receivable	-	9,712	6,736	6,508	4,533	4,392
Other Receivables	-	129.53	100.05	39.78	129.68	444.95
Receivables	-	9,841	6,836	6,549	4,745	4,837
Inventory	-	3,139	2,555	2,480	1,861	2,536
Other Current Assets	-	-	-	-	-	562.22
Total Current Assets	-	26,745	23,957	20,337	15,921	13,697
Property, Plant & Equipment	-	11,643	10,977	9,564	8,934	9,282
Long-Term Investments	-	4,596	3,720	3,323	2,710	1,486
Goodwill	-	234.9	234.9	149.98	149.98	188.96
Other Intangible Assets	-	2,146	1,872	425.87	494.6	1,128
Long-Term Deferred Tax Assets	-	186.78	113.03	43	117.47	34.84
Long-Term Deferred Charges	-	52.53	35.81	41.98	14.15	8.08
Other Long-Term Assets	-	678.51	859.31	857.51	1,728	493.81
Total Assets	-	46,282	41,770	34,742	30,070	26,318
Accounts Payable	-	2,889	2,206	1,770	1,359	1,532
Accrued Expenses	-	7.55	3,922	3,166	2,337	1,906
Short-Term Debt	-	441.27	145.64	-	99	23
Current Portion of Long-Term Debt	-	8.95	7.84	-	-	-
Current Portion of Leases	-	149.63	142.07	38.42	124.84	74.24
Current Income Taxes Payable	-	379.45	261.61	260.73	378.84	258.82
Current Unearned Revenue	-	494.9	940.5	645.75	745.17	708.86
Other Current Liabilities	-	5,812	1,333	1,346	1,258	1,734
Total Current Liabilities	-	10,183	8,958	7,226	6,302	6,237
Long-Term Debt	-	-	28.95	-	-	-
Long-Term Leases	-	107.06	258.04	55.62	92.88	90.3
Long-Term Unearned Revenue	-	340.53	270.92	250.2	253.97	154.73
Long-Term Deferred Tax Liabilities	-	574.84	611.99	381.48	320.44	304.43
Other Long-Term Liabilities	-	59.16	-	-	-	13.92
Total Liabilities	-	11,264	10,128	7,913	6,969	6,800
Common Stock	-	10,899	10,899	10,899	10,899	10,899
Additional Paid-In Capital	-	390.53	196.57	46.79	46.79	46.79
Retained Earnings	-	26,245	23,192	19,188	15,197	11,494
Treasury Stock	-	-316.21	-83.71	-85.6	-100.71	-100.71
Comprehensive Income & Other	-	-4,015	-4,006	-4,062	-3,710	-3,878
Total Common Equity	34,851	33,203	30,198	25,987	22,332	18,462
Minority Interest	-	1,815	1,444	841.56	768.79	1,056
Shareholders' Equity	36,472	35,018	31,642	26,828	23,101	19,518
Total Liabilities & Equity	-	46,282	41,770	34,742	30,070	26,318
Total Debt	388.87	706.9	582.54	94.04	316.71	187.54
Net Cash (Debt)	10,428	13,058	13,984	11,213	8,999	5,574
Net Cash Growth	-	-6.62%	24.70%	24.61%	61.43%	8.25%
Net Cash Per Share	0.88	1.10	1.17	0.94	0.75	0.47
Filing Date Shares Outstanding	11,709	11,852	11,917	11,918	11,955	11,955
Total Common Shares Outstanding	11,709	11,852	11,917	11,918	11,955	11,955
Working Capital	-	16,562	14,999	13,110	9,620	7,460
Book Value Per Share	2.95	2.80	2.53	2.18	1.87	1.54
Tangible Book Value	32,376	30,822	28,090	25,411	21,688	17,145
Tangible Book Value Per Share	2.74	2.60	2.36	2.13	1.81	1.43
Buildings	-	5,389	4,639	4,135	3,569	3,676
Machinery	-	9,194	7,317	6,723	5,961	6,168
Construction In Progress	-	1,246	2,245	1,534	1,483	1,905

Source: S&P Capital IQ. Standard template. Financial Sources.